MDMAPharmala Biotech HoldingsMDMA info
$0.06info0.00%24h
Global rank34389
Market cap$5.28M
Change 7d-5.56%
YTD Performance-41.38%
SP500 benchmarkUnderperform
P/E-6.24
P/S13.51
Revenue$390.76K
Earnings-$572.78K
Dividend yield-
Main Sector
Healthcare

Pharmala Biotech Holdings (MDMA) Stock Overview

Pharmala Biotech Holdings Inc., doing business as PharmAla, focuses on the developing, manufacturing, and commercializing of substituted methylenedioxy-phenethylamines (MDXX) active pharmaceutical ingredients. It also provides MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB); and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), as well as formulations of MDXX compounds. The company is headquartered in Vancouver, Canada.

MDMA Stock Information

Symbol
MDMA
Address
1111 Melville StreetVancouver, BC V6E 3V6Canada
Founded
-
Trading hours
-
Website
https://pharmala.ca
Country
🇨🇦 Canada
Phone Number

Pharmala Biotech Holdings (MDMA) Price Chart

-
Value:-

Pharmala Biotech Holdings Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.06243343494068824
N/A
Market Cap
$5.28M
N/A
Shares Outstanding
84.53M
5.98%
Employees
0
N/A
Shareholder Equity
1.38M
-27.42%
Valuation
2023
Change
P/E Ratio
-6.24
N/A
P/S Ratio
13.51
N/A
P/B Ratio
3.81
N/A
Growth
2023
Change
Return on Equity
-0.4140
N/A
Earnings
2023
Change
Revenue
$390.76K
N/A
Earnings
-$572.78K
N/A
EPS
-0.01
N/A
Earnings Yield
-0.1602
N/A
Gross Margin
0.8536
N/A
Operating Margin
-1.43
N/A
Net income margin
-1.47
N/A
Financial Strength
2023
Change
Total Assets
$1.77M
N/A
Cash on Hand
$143.26K
N/A
Debt to Equity
0.5463
234.57%
Current Ratio
0.6938
-72.91%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org